Year : 2010 | Volume
: 55 | Issue : 1 | Page : 20--24
A study of androgen and estrogen receptors α, β in skin tags
Omar El Safoury1, Lila Rashid2, Magdy Ibrahim3,
1 Department of Dermatology, Faculty of Medicine, Cairo University, Egypt
2 Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt
3 Department of Obstetrics and Gynecology, Research Biostatistics Unit, Management Team, EBM Unit, MEDC, Faculty of Medicine, Cairo University, Egypt
Omar El Safoury
Department of Dermatology, Faculty of Medicine, Cairo University
Background: In women, the age of 50 is suggested to be the turning point of life at which the development of skin tags comes to a stop. A major event that occurs around this period of life is menopause/andropause. After menopause, estrogen receptors amounts decrease significantly. As skin is considered as the largest nonreproductive target on which estrogens and androgens act, we assume a possible relationship between the pathogenesis of skin tags and sex steroid balance. Another phenomenon is the association of skin tags in obese patients, which may also be explained by the interplay of sex steroids and their receptors in skin tags. Aims: Here we see that in obese patients, hyperandrogenism occurs as a result of hyperinsulinemia as well as peripheral conversion of estrogens into androgens in the excessive adipose tissue. To examine the possible role of androgen and estrogen receptors in etiopathogenesis of skin tags. Materials and Methods: To examine these hypotheses, we measured the level of androgen and estrogen receptors (both α and β) in skin tags compared to control. We also correlated the level of receptors to body mass index, and compared those levels in patients with acanthosis nigricans compared to normal. Results: The level of estrogen receptors (both α and β) was significantly higher in skin tags than in controls with a P value of 0.004 and 0.001, respectively. The same upsurge was found for androgen receptors in skin tags relative to control with a P value of 0.001. No statistically significant difference in receptor level was found either among patients with acanthosis nigricans and those without, or in correlation to body mass index (our participants were overweight non diabetic). Conclusion: These results suggest the possible role of androgen and estrogen receptors in etiogenesis of skin tags, and propose that the neck is an androgen dependent area just similar to the axillae and the groins, though hairless.
|How to cite this article:|
El Safoury O, Rashid L, Ibrahim M. A study of androgen and estrogen receptors α, β in skin tags.Indian J Dermatol 2010;55:20-24
|How to cite this URL:|
El Safoury O, Rashid L, Ibrahim M. A study of androgen and estrogen receptors α, β in skin tags. Indian J Dermatol [serial online] 2010 [cited 2022 Oct 2 ];55:20-24
Available from: https://www.e-ijd.org/text.asp?2010/55/1/20/60345
Estrogen, the predominant steroid responsible for secondary sexual characteristics in females, influences the function of all major organ systems within the body. Skin constitutes the largest nonreproductive target on which estrogen acts.  Estrogens are C-18 steroids synthesized from cholesterol in the ovary and in peripheral tissues, especially adipose tissue. In postmenopausal women, estrogen synthesis is restricted to peripheral tissues. In the latter, the enzyme aromatase is responsible for conversion of the androgen androstenedione to estradiol. While aromatase enzyme is present in the ovarian theca cells, bone, brain, and skin, the majority of peripheral production of estrogen occurs in the skin. 
Several phenomena point to a tight relationship between skin homeostasis and sex steroids. Among those are skin tags that manifest exclusively in postpubertal life,  and stop developing following menopause,  which can be theoretically explained by their dependence on sex steroids, the receptors of which fade following menopause.  This is in addition to other phenomena such as increased incidence of soft fibromas during pregnancy. 
On the other hand, among massively obese males, who exhibit decline in total and free testosterone as well as elevated esrtadiol levels,  and among obese females with syndrome X who suffer high androgen levels, decreased sex hormone binding globulin level and polycystic ovaries are observed.  These phenomena further support the theory that estrogens and androgens are involved in the pathogenesis of various cutaneous disorders among which are skin tags.
The aim of this study is to examine the possible role of androgen and estrogen receptors in etiogenesis of skin tags.
Materials and Methods
This study included 15 participants, including 12 females and 3 males, attending the outpatient clinic of the dermatology unit. Their complaint was cosmetically unappealing skin tags. Mean age was 34.20 ± 6.603 years. All participants were nondiabetic. Patients were examined for the number of skin tags, color, the presence, or absence of acanthosis nigricans, body mass index (BMI), in addition to the routine general examination and examination of the skin for concomitant pathology.
BMI was calculated according to the following equation: 
BMI = weight (Kg)/height (m 2 )
The levels of androgen receptors (AR), estrogen receptors α (ERα), and estrogen receptors β (ERβ) were estimated by taking a skin snip spanning one of the skin tags as a study sample, and a piece of the surrounding area as a control sample and evaluating each separately by reverse transcription-polymerase chain reaction (RT-PCR).
Reverse transcription-polymerase chain reaction
Total RNA was extracted from the study sample and control sample by the acid guanidinum thiocyanate-phenol-chloroform method R1.  RNA content and purity were measured by a UV spectrophotometer. The A260/A280 ratio was 1.8 to 2.0. RNA was of high integrality, being detected by agarose gel electrophoresis.
Reverse transcription-polymerase chain reaction procedure
RT-PCR was performed using the extracted RNA for the detection of estrogen and androgen receptor genes. For the amplification of the targets genes, reverse transcription and PCR were run in two separate steps. Equal amounts of total RNA (6 µg) were heat denatured and reverse transcribed by incubation at 42 o C for 90 min with 12.5 U avian myeloblastosis virus (AMV) reverse transcriptase (Promega Corp., Madison, WI), 20 U ribonuclease inhibitor RNasin (Promega Corp.), 200 nM deoxy-nucleoside 5'-triphosphate mixture, and 1 nM oligo-dT primer in a total volume of 30 µl of 1x avian myeloblastosis virus reverse transcriptase buffer. The reactions were terminated by heating at 97 o C for 5min and cooling on ice. cDNA samples were amplified in 50 µl of ×1 PCR buffer in the presence of 2.5 U Taq DNA polymerase (Promega Corp.), 200 nM deoxy-nucleoside 5'-triphosphate mixture, and the appropriate primer pairs (1 nM of each primer). These sets of primers, their annealing temperatures, and product sizes are listed in [Table 1].
PCR started with an initial denaturing cycle at 978C for 5min , followed by a variable number of amplification cycles comprising denaturation at 968C for 1.5 min, annealing for 1.5min, and extension at 72 o C for 3 min. A final extension cycle of 72 o C for 15 min was performed.
Agarose gel electrophoresis
All PCR products were electrophoresed on 2% agarose stained with ethidium bromide and visualized by UV transilluminator.
Semi-quantitative determination of PCR products
Semi- quantitation was performed using the gel documentation system (BioDO, Analyser) supplied by (Biometra) according to the following amplification procedure: Relative expression of each studied gene (R) was calculated following the formula:
R = Densitometrical units of each studied gene/ Densitometrical units of β-actin.
PCR detection of β-actin
Presence of RNA in all samples was assessed by analysis of the "house-keeping" gene β-actin. cDNA was generated from 1µg of total RNA extracted with AMV reverse transcriptase for 60min at 37°C. For PCR, 4 µl cDNA was incubated with 30.5 µl water, 4 µl 25 mM MgCl 2 , 1 µl dNTPs (10 mM), 5 µl ×10 PCR buffer, 0.5 µl (2.5U) Taq polymerase and 2.5 µl of each primer containing 10 pmol. β-actin primers (forward 5-TGTTGTCCCTGTATGCCTCT-3. reverse 5-TAATGTCACGCACGATTTCC-3) were designed from GenBank (accession no. J00691). The reaction mixture was subjected to 40 cycles of PCR amplification as follows: Denaturation at 95°C for 1min, annealing at 57°C for 1min and extension at 72°C for 2min. The PCR product yielded 206 bp fragments.
PCR amplification as follows: Denaturation at 95°C for 1min, annealing at 57°C for 1min and extension at 72°C for 2min. The PCR product yielded 206 bp fragments.
Data were statistically described in terms of range, mean ± standard deviation (±SD), frequencies (number of cases) and relative frequencies (percentages) when appropriate. Comparison of quantitative variables between acanthosis nigricans (AN) and non (AN) groups was done using Mann- Whitney U test for independent samples. Comparison of quantitative variables between cases and control samples was done using Wilcoxon signed rank test. Correlations between various variables were made using the Spearman rank correlation equation. A probability value (P value) less than 0.05 was considered statistically significant. All statistical calculations were done using the computer programs: Microsoft Excel version 7 (Microsoft Corporation, NY, USA) and SPSS (Statistical Package for the Social Science; SPSS Inc., Chicago, IL, USA).
Mean skin tag number for participants was 40 ± 15.67. Skin tags were flesh-colored (F) in 7 participants and mixed (hyper pigmented and flesh color) (M) in 8 [Table 2] with no statistically significant difference between cases with acanthosis nigricans and those without. Seven patients exhibited acanthosis nigricans and eight did not. Mean body mass index (BMI) was 27.989 ± 4.5395. The internationally accepted interpretation for BMI is as follows: Underweight: 40, which makes the participants mostly overweight.
Average androgen receptors level (AR) was (0.9613 ± 0.61154) in skin tags and (0.2386 ± 0.23613) in control samples of healthy skin. This higher level in skin tags was statistically significant with a P value of 0.001 [Figure 1]. Estrogen receptors α level (ERα) was higher in skin tags (0.1693 ± 0.14714) than in control (0.0600 ± 0.03094). This difference was statistically significant, with a P value of 0.004 [Figure 1]. Similarly, estrogen receptors β level (ERβ) was higher in skin tags than it was in healthy skin, (1.3133 ± 0.56001) and (0.1573 ± 0.10754) respectively, a statistically significant finding (P value 0.001) [Figure 1].
No statistically significant difference was noted in receptor levels between participants with acanthosis nigricans and those without [Figure 2]. There was no significant correlation between body mass index and levels of androgen and estrogen receptor α and β [Table 3].
Skin tags are related to obesity,  and a hormonal mechanism has been suggested in obese females, especially those with upper body obesity, where there is increased peripheral aromatization of androgens to estrogens  [See arrow-1 of [Figure 3]]. Similar hormonal imbalance exists in obese males where estrogen levels in blood increase in a direct proportion with body mass index (BMI).  Obese men have elevated levels of estrone, both free and total, as well as estradiol. Plasma estrogen levels do not decrease even after massive weight reduction.  This may be an underlying mechanism of skin tag development in obese men. However, our results contradict the fore mentioned study, where there was no statistically significant correlation between BMI and androgen or estrogen receptors levels as our participants were overweight non diabetic.
Our results point out to a significant estrogen receptor levels and the development of skin tags, which in turn explains the absence of skin tags before puberty and the arrest of their development following menopause.
The following is a possible cascade of events that explains the role of estrogen concentration and receptor levels in the development of skin tags on the cellular scale: Keratinocytes express both estrogen receptors (ERα and ERβ) [See arrow-3 of [Figure 3]]. Estradiole binds to keratinocytes with high affinity, and in its normal physiological range increases the regulation of the level of ERβ receptors and induces keratinocyte proliferation.  In addition, estrogen targets human skin fibroblasts. 17β-estradiol has been shown to increase fibroblast proliferation in human skin [See arrow-5 of [Figure 3]]. Finally, there is a role for mast cells interacting with fibroblasts and keratinocytes in the course of the development of skin tags [arrows without number in [Figure 3]].  Mast cells express high-affinity estrogen receptors [See arrow-4 of [Figure 3]]. 17 β- estradiol augments secretion of histamine and serotonin.  Binding of estradiol, in physiological concentrations, to a membrane estrogen receptor α, initiates a rapid onset, progressive influx of extra-cellular Ca(2+), inducing exocytosis of mast cell products. 
A similar role can be hypothesized for androgens and their receptors, especially in obese females with upper body obesity who exhibit insulin resistance, hyperandrogenemia, hyperinsulinemia, altered gonadotrophin and insulin-like growth factor binding proteins (IGFBPs), increased leptin levels and altered neuro-regulation of hypothalamic-pituitary-gonadal axis  [See arrow-2 of [Figure 3]]. This role is supported by our results and by previous observations. It was found that blocking androgen receptors with sex hormone antagonists in the testis of frog Rana esculenta causes a significant increase in mast cell count, supporting the involvement of androgens in mast cell proliferation and/or differentiation  [See arrow-6 of [Figure 3]]. On the contrary, it was found that testosterone and tamoxifen have an inhibitory effect on mast cell secretion of histamine and serotonin in rats.  Considering the fact that mast cells are a major player in the development of skin tags,  and the effect of androgens on their concentration and behavior, androgens can have a role in the pathogenesis of skin tags. Despite the reported absence of androgen receptors in the epidermis,  dermal fibroblasts in androgen dependent areas have androgen receptors with binding affinity for circulating androgens  [See arrow-7 of [Figure 3]].
According to our results, the higher level of estrogen α and β as well as the androgen receptors in association with skin tags, represents strong evidence of the pathogenesis of sex hormones in this disease, and propose that the neck is an androgen dependent area just similar to the axillae and the groins, though hairless.
|1||Hall G, Phillips TJ. Estrogen and skin. The effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 2005;53:555-68.|
|2||Banik R, Lubach D. Skin Tags. Localization and Frequencies According to Sex and Age. Dermatologica 1987;174:180-3.|
|3||Meza-Muñoz DE, Fajardo ME, Pérez-Luque EL, Malacara JM. Factors associated with estrogen receptors-α (ER-α) and -β (ER-β) and progesterone receptor abundance in obese and non obese pre- and post-menopausal women. Steroids 2006;71:498-503.|
|4||Brickner, SM. Fibroma molluscum gravidarum. Am J Derm genito-urin Dis. 1912;16:240.|
|5||Cohen PG. The hypogonadal-obesity cycle: Role of aromatase in modulating the testosterone-estradiol shunt- a0 major factor in genesis of morbid obesity. Med Hypotheses 1999;52:49-51.|
|6||Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization more than just syndrome X. Comp Biochem Physiol A Mol Integr Physiol 2003;136:95-112.|
|7||Eknoyan G. Adolphe Quetelet (1796-1874) - t0 he average man and indices of obesity. Nephrol Dial Transplant 2008;23:47-51.|
|8||Chomczynski P, Sacchi N. Single step method for RNA isolation by the acid guanidinum thiocyanate-phenol-chloroform method. Anal Biochem 1987;162:156-60.|
|9||Puneet Bhargara. Deepak Mathur. Acrochordon, diabetes and associations. Indian J of Dermal and Veneriol 1996;62(4) 226-8.|
|10||Diamanti-Kandarakis E, Bergiele A. The influence of obesity on hyperandrogenism and infertility in the female. Obes Rev 2001;2:231-7.|
|11||Bélanger C, Hould FS, Lebel S, Biron S, Brochu G, Tchernof A. Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids 2006;71:674-82.|
|12||Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand 1988;723:153-60.|
|13||Verdier-Sevrain S, Yaar M, Cantatore J, Traish A, Gilchrest BA. Estradiol induces proliferation of keratinocytes via receptor-mediated mechanisms. FASEB J 2004;18:1252-4.|
|14||Tomaszewski J, Adamiak A, Skorupski P, Rzeski W, Rechberger T. Effect of 17 â estadiol and phytoestrogen daidzein on the proliferation of pubocervical fascia and skin fibroblasts derived from women suffering from stress urinary incontinence. Ginekol Pol 2003;74:1410-4.|
|15||Zaher H, El Safoury OS, El Komy MM, Mahmoud SB, El Hameed HA. Study of mast cell count in skin tags. Indian J Dermatol 2007;52:184-7|
|16||Di Matteo L. Vitieello I.I and Minucci S. Effect of sex steroid hormones and antagonists on mast cell number in the testis of frog. Rana esculenta Zygot 2000;8:225-34.|
|17||Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, et al. Estradiol activates mast cells via a non-genomic estrogen receptor-α and calcium influx. Mol Immunol 2007;44:1977-85.|
|18||Vliagoftis H, Dimitriadou V, Boucher W, Rozniecki JJ, Correia I, Raam S, et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol 1992;98:398-409.|
|19||Hamilton KS, Johnson S, Smoller BR. Role of androgen receptors in clinical course of Nevus Sebaceus of Jadassohn. Mod Pathol 2001;14:539-49.|
|20||Eil C, Cutler GB Jr, Loriaux DL. Androgen receptor characteristics in skin fibroblasts from hirsute women. J Invest Dermatol 1985;84:62-5.|